NSE filing, NSE: OMKARCHEM. Summary written from the filing by ALFA Finder's alert engine.
More from Omkar Speciality Chemicals Limited
All →Omkar Speciality Chemicals Insolvency Petition
Omkar Speciality Chemicals Limited announced a Broad Step Plan under its NCLT-approved Resolution Plan. Key actions include reducing the entire existing share capital to zero, issuing fresh equity to the Resolution Applicant, and conducting a 5% Offer for Sale to achieve Minimum Public Shareholding compliance.
Omkar Speciality Chemicals Management Change
Omkar Speciality Chemicals Limited has appointed Mahendra Jain as Chief Financial Officer and Kuldeep Manaria as Company Secretary and Compliance Officer, effective April 15, 2026. Mr. Jain brings over 46 years of manufacturing experience, while Mr. Manaria has 6 years of expertise in corporate secretarial and legal compliances.
Omkar Speciality Chemicals Board Meeting Outcome
Omkar Speciality Chemicals' Monitoring Committee will meet on April 15, 2026, to determine the record date for share cancellation and approve a ₹5 Crore private placement. The meeting will also consider the appointment of a new CFO and Company Secretary as part of its resolution plan.
- Value
- ₹5.00 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.